Literature DB >> 10955230

[Diagnosis and therapy of laryngitis gastrica].

J Pahn1, A Schlottmann, G Witt, W Wilke.   

Abstract

We treated 64 patients with the diagnosis of laryngitis gastrica with Antra (Omeprazol) in doses of 10, 20, and 40 mg. To determine the success of the therapy, pH monitoring of the esophagus and hypopharynx, the voice status and measurement of vocal penetrating capacity were used. The results prove that a 20-mg dose of Antra is suitable for the therapy of laryngitis gastrica with a high rate of success. Problems which arose during the investigation, consequent changes of the original concept of the project as well as new aspects and questions which resulted from this are discussed with respect to further investigation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10955230     DOI: 10.1007/s001060050609

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  2 in total

1.  [Laryngopharyngeal reflux: change in paradigm or diagnostic catchall?].

Authors:  C Sittel
Journal:  HNO       Date:  2003-09       Impact factor: 1.284

2.  [The need for 24-h double probe pH monitoring in the diagnosis of laryngo-pharyngeal reflux].

Authors:  P Jecker; R Schuon; W J Mann
Journal:  HNO       Date:  2003-04-09       Impact factor: 1.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.